Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Mar 18, 2015
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
The secondary objectives of this study are:
* To estimate changes in several microbiological parameters over three time periods (before treatment, after applying the Metvixia® and after irradiation during a single TDP session).
* Describe the evolution of the size and appearance of the wound 7d after the start of treatment
* Describe the potential adverse events associated with a TDP session
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient correctly informed concerning study implementation, objectives, constraints and patient rights
- • The patient must have given his/her informed and signed consent
- • The patient must be insured or beneficiary of a health insurance plan
- • The patient presents with one or more leg ulcers (artieral, venous or mixed)
- • Afebrile patient without periulcerous erythema and who does not require antibiotic therapy
- • Patient who has not received antibiotic treatment during the last 7 Days
- • Nota bene: Patients with multiple ulcers at different stages will be included for the wound corresponding to the highest stage. If the patient has multiple ulcers atn the same stage, the deepest wound will be considered.
- Exclusion Criteria:
- • The patient is participating in another interventional study, has participated in another interventional study with the past 3 months, or is in an exclusion period determined by a previous study
- • The patient is under judicial protection, under tutorship or curatorship
- • The patient refuses to sign the consent
- • It is impossible to correctly inform the patient
- • The patient is pregnant, parturient, or breastfeeding
- • The patient has a contraindication for a treatment used in this study
- • Patient with an infected leg ulcer treated with antibiotics
- • Patients on curative anticoagulation
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nîmes Cedex 09, , France
Patients applied
Trial Officials
Laurent Meunier, MD, PhD
Principal Investigator
Centre Hospitalier Universitaire de Nîmes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials